Leveraging An Insight-Driven Trial Strategy

In the rapidly evolving clinical trial landscape, characterized by technological advancements, patient-centric solutions, and shifting regulatory demands, optimizing patient recruitment and retention is paramount. An insight-driven approach, facilitated by robust analytics, is essential for understanding patients' motivations and burdens, thus enhancing their research experience.

IQVIA's Data Informed Protocol Assessment (DIPA) empowers sponsors to assess and optimize trial protocols based on evidence-based insights, thereby reducing patient burden and improving recruitment and retention. Case studies demonstrate the efficacy of DIPA in optimizing trial design, particularly in reducing site visits, patient-reported outcomes, and ECG frequency. Moreover, leveraging DIPA insights facilitates diversity and inclusion efforts by addressing barriers to participation.

Looking ahead, insight-driven strategies will continue to shape the dynamic clinical trial landscape, emphasizing the importance of listening to patients for improved trial design and delivery.